Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Gross Profit (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Gross Profit data on record, last reported at $5.6 million in Q3 2025.

  • For Q3 2025, Gross Profit fell 3.41% year-over-year to $5.6 million; the TTM value through Sep 2025 reached $22.1 million, down 14.89%, while the annual FY2024 figure was $24.1 million, 19.63% down from the prior year.
  • Gross Profit reached $5.6 million in Q3 2025 per UTMD's latest filing, roughly flat from $5.6 million in the prior quarter.
  • Across five years, Gross Profit topped out at $8.3 million in Q4 2022 and bottomed at $5.3 million in Q4 2024.
  • Average Gross Profit over 5 years is $7.1 million, with a median of $7.4 million recorded in 2023.
  • Peak YoY movement for Gross Profit: soared 57.27% in 2021, then dropped 25.01% in 2024.
  • A 5-year view of Gross Profit shows it stood at $8.1 million in 2021, then increased by 2.65% to $8.3 million in 2022, then decreased by 14.76% to $7.1 million in 2023, then decreased by 25.01% to $5.3 million in 2024, then grew by 5.28% to $5.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $5.6 million in Q3 2025, $5.6 million in Q2 2025, and $5.5 million in Q1 2025.